Critical Contrast: Vivani Medical (NASDAQ:VANI) & Nexeon Medsystems (OTCMKTS:NXNN)

Nexeon Medsystems (OTCMKTS:NXNN) and Vivani Medical (NASDAQ:VANI) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation and institutional ownership.

Insider & Institutional Ownership

6.8% of Vivani Medical shares are owned by institutional investors. 61.2% of Nexeon Medsystems shares are owned by company insiders. Comparatively, 44.3% of Vivani Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares Nexeon Medsystems and Vivani Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nexeon Medsystems	N/A	N/A	N/A	N/A	N/A
Vivani Medical	N/A	N/A	-$25.65 million	($0.44)	-2.39

Analyst Recommendations

This is a breakdown of recent recommendations for Nexeon Medsystems and Vivani Medical, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nexeon Medsystems	0	0	0	0	0.00
Vivani Medical	0	0	1	0	3.00

Vivani Medical has a consensus price target of $4.00, suggesting a potential upside of 280.95%. Given Vivani Medical’s stronger consensus rating and higher possible upside, analysts clearly believe Vivani Medical is more favorable than Nexeon Medsystems.

Volatility and Risk

Nexeon Medsystems has a beta of 6.98, indicating that its share price is 598% more volatile than the S&P 500. Comparatively, Vivani Medical has a beta of 2.76, indicating that its share price is 176% more volatile than the S&P 500.

Profitability

This table compares Nexeon Medsystems and Vivani Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Nexeon Medsystems	N/A	N/A	N/A
Vivani Medical	N/A	-102.42%	-49.21%

About Nexeon Medsystems

Nexeon MedSystems Inc., a medical device company, develops, manufactures, and commercializes neurostimulation technology for the treatment of various neurological disorders through electrical stimulation of neural tissues. Its neurostimulation technology platform would provide treatment to patients in several neurostimulator markets, including deep brain stimulation, peripheral electrical nerve stimulation, sacral nerve stimulation, spinal cord stimulation, vagus nerve stimulation, and other neurostimulator markets. The company develops the Viant, a deep brain stimulation system for Parkinson's disease in the United States, as well as for Parkinson's disease, Essential Tremor, and Dystonia in Europe. Nexeon MedSystems Inc. was founded in 2015 and is based in Dallas, Texas.

About Vivani Medical

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.